Study Stopped
Covid-19 Pandemic halted my study due to exposure risks.
Effect of Dry Roasted Peanuts and Boiled Peanuts on Glycemic Control
1 other identifier
interventional
24
1 country
1
Brief Summary
Research on glycemic control related to nuts or whole snack foods has focused primarily on tree nuts. Different processing and cooking methods have not been comprehensively analyzed to observe the effect on nutrient quality, bioavailability, or digestive absorption in peanuts. There is little to no research surrounding the nutrition of boiled peanuts so it may be of interest to compare boiled to roasted peanuts in terms of glycemic control. Peanuts have been shown to have a similar beneficial effect on glycemic control while being more financially accessible than almonds. Glycemic control could be improved based on the low glycemic index, high fiber, lipid, and or protein content of peanuts. The acute trial (phase 1) will investigate the impact of preprandial peanut consumption on glycemic response. The participants will complete an oral glucose tolerance test for both roasted and boiled peanuts. The long term study (phase 2\&3) consists of participants consuming one serving per day of boiled or roasted peanuts in a four week crossover trial to observe any long term impact of daily peanut snacking on glycemic control. (Wash out weeks occurring between all trials.) At the conclusion of phase 2 \& 3 an oral glucose tolerance test will be executed. The subjects will self record a exercise/step count and diet dairy, weight and waist to hip ratio will be measured weekly. The study will aim for a male and/or female healthy population from 18-65 years of age at NCSU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus
Started Mar 2020
Shorter than P25 for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2019
CompletedFirst Posted
Study publicly available on registry
November 21, 2019
CompletedStudy Start
First participant enrolled
March 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 18, 2020
CompletedOctober 5, 2020
September 1, 2020
15 days
November 15, 2019
September 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline Blood Glucose Response (Glycemic Response)
The blood glucose response will be measured during each oral glucose tolerance test. These tests will happen periodically through out the study to determine if there is any correlation and or significant difference in glycemic response between consuming boiled or roasted peanuts (acute and chronic consumption). The metric is the blood glucose concentration measured by a blood glucose monitor by finger prick 10 times over a two hour period after consuming a standardized 50 gram glucose beverage. The 10 blood glucose measurements are synthesized into one measurement to display a pattern of blood glucose concentrations called the glycemic response. Please refer to Study Description -Detailed Description for a more thorough explanation.
[week 1 - phase 1 - three measurements mon/wed/fri] [week 2 - wash out week] [week 3 & week 4- phase 2 - one measurement at the end of week 4] [week 5 - wash out week] [week 6 & week 7 - phase 3 - one measurement at end of week 7]
Secondary Outcomes (2)
weight change
Once week one, once week 4, once week 8.
waist to hip ratio
Once week one, once week 4, once week 7.
Study Arms (2)
Roasted Peanut Group 1
EXPERIMENTALArm 1 is the arm of participants that will receive the roasted peanut treatment first and then will crossover to the boiled peanut treatment.
Boiled Peanut Group 1
EXPERIMENTALArm 2 is the arm of participants that will receive the boiled peanut treatment first then will crossover to the roasted peanut treatment.
Interventions
The subjects will consume 2 ounces or \~48 grams of roasted in shell peanuts a day for two weeks.
The subjects will consume 2 ounces or \~48 grams of boiled peanuts a day for two weeks.
Eligibility Criteria
You may qualify if:
- Men and women with ages 18 to 65
- BMI ranges \[(in kg/m2) 18.5\>24.9\] from Raleigh-Durham area 3. We will not recruit pregnant women
You may not qualify if:
- BMI \>24.9 kg/m2 or \<18 kg/m2
- Type 1 or 2 diabetes
- Anemia
- Fasting glucose \>125 mg/dL
- Use of medication that affect glucose metabolism, renal, liver, pancreatic, or cardiovascular disease.
- Uncontrolled hypertension
- Disorders of the esophageal or in gastrointestinal motility
- Hypo- or hyperthyroidism
- Allergy to peanuts
- Pregnancy.
- Body weight \< 110 lb
- Insulin Resistance
- Polycystic Ovary Syndrome
- Food intolerances
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
North Carolina State University
Raleigh, North Carolina, 27607, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jonathan C Allen, PhD
North Carolina State University
- STUDY DIRECTOR
Lisa Dean, PhD
USDA ARS - Market Quality and Handling Unit, North Carolina State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The nature of the participants eating (whole food) peanut samples roasted or boiled allows no way for the participants or the investigators to be masked from the two interventions. The care provider does not apply in this study and the outcomes assessor will be the same individual as the investigator.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master of Science Nutrition (Thesis) Graduate Student
Study Record Dates
First Submitted
November 15, 2019
First Posted
November 21, 2019
Study Start
March 2, 2020
Primary Completion
March 17, 2020
Study Completion
March 18, 2020
Last Updated
October 5, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share
The de-identified individual participant data will not be shared unless the study is successful and is published.